Estrogen and Smooth Muscle Cell Estrogen Receptor Alpha Modulate Arterial Stiffness

Casey G. Turner,Gregory Martin,Qing Lu,Zhe Sun,Iris Z. Jaffe,Michael A. Hill,Jennifer Dupont
DOI: https://doi.org/10.1161/atvb.43.suppl_1.722
IF: 9.8968
2023-01-01
Hypertension
Abstract:Background: Aging is associated with increasing arterial stiffness (AS), an independent risk factor for cardiovascular disease. While estrogen and estrogen receptor alpha (ERα) are protective in premenopausal females, the role of estrogen/ERα in aging-associated AS has not been defined and the mechanisms of the sexually-dimorphic development of aging-associated AS are unknown. We hypothesize that ERα contributes to sex differences in aging-associated AS. Methods/Results: We created novel smooth muscle cell-specific (SMC) ERα knockout mice (SMC-ERα-KO) and measured aortic pulse wave velocity (PWV), an index of AS, in 3, 12, and 18 mo old male and female intact and KO mice. Male mice develop AS at 12 mths compared to 18 mths in females (p<0.05, n=5-7/group). Deletion of SMC-ERα- protected females from the aging-associated increase in AS (p<0.05, n=5-7/group). Circulating estrogens declined in 18 mth old females vs. 3 mth. (p<0.05, n=6/group), suggesting a role for unliganded SMC-ERα in aging-associated AS. We also measured aortic gene expression of the vasoprotective angiotensin II type 2 receptor (AT2R) and found SMC-ERα-KO females were protected from the aging-associated decline in aortic AT2R expression observed in intact females (p<0.05, n=3-5/group), suggesting SMC-ERα regulates AT2R expression. To investigate the in vivo role of unliganded SMC-ERα in AS, we performed ovariectomy (OVX) or sham surgeries in young female intact and KO mice. We observed an OVX-driven increase in AS that was prevented by SMC-ERα-KO (p<0.05, n=5/group). This was also associated with an OVX-mediated decrease in aortic expression of AT2R, which was prevented by SMC-ERα-KO (p<0.05, n=5/group). In vitro studies also demonstrated that estrogen upregulates AT2R mRNA and protein expression in female mouse aortic SMC (p<0.05, n=5/group), supporting an estrogen-mediated mechanism of AT2R driven vascular protection in females that appears to be lost with age. Conclusion: These data indicate that with age, as circulating estrogens decline, SMC-ERα becomes detrimental and contributes to the development of aging-associated AS via reductions in AT2R in females. Further, these results suggest that AT2R agonist therapy may improve cardiovascular outcomes in aging women.
What problem does this paper attempt to address?